About Trem-like transcript 1 protein
Trem-like transcript 1 protein (TREML1) is a protein
from Homo sapiens identified by UniProt accession
Q86YW5, 311 residues long.
MolForge cross-references it against 0 known binders and
126 disease associations.
Target properties
| Protein name | Trem-like transcript 1 protein |
| UniProt accession | Q86YW5 |
| Gene | TREML1 |
| Organism | Homo sapiens |
| Length | 311 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (126)
Diseases linked to this target (Open Targets).
- monocyte count · score 0.12
- blood protein measurement · score 0.12
- Parkinson disease · score 0.09
- Rare hemorrhagic disorder due to a constitutional platelet anomaly · score 0.07
- neutrophil count · score 0.07
- Glanzmann thrombasthenia 1 · score 0.07
- Von Willebrand disease · score 0.06
- Bernard-Soulier syndrome · score 0.06
- leukocyte count · score 0.06
- macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss · score 0.06
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q86YW5-F1 | alphafold | PREDICTED | 68.98 | — |
Amino-acid sequence (311 residues)
MGLTLLLLLL LGLEGQGIVG SLPEVLQAPV GSSILVQCHY RLQDVKAQKV WCRFLPEGCQ PLVSSAVDRR APAGRRTFLT DLGGGLLQVE MVTLQEEDAG EYGCMVDGAR GPQILHRVSL NILPPEEEEE THKIGSLAEN AFSDPAGSAN PLEPSQDEKS IPLIWGAVLL VGLLVAAVVL FAVMAKRKQG NRLGVCGRFL SSRVSGMNPS SVVHHVSDSG PAAELPLDVP HIRLDSPPSF DNTTYTSLPL DSPSGKPSLP APSSLPPLPP KVLVCSKPVT YATVIFPGGN KGGGTSCGPA QNPPNNQTPS S
Explore Trem-like transcript 1 protein with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets